Blocklisting Interim Review

RNS Number:3511G
GW Pharmaceuticals PLC
25 October 2007



                        BLOCKLISTING SIX MONTHLY REVIEW


1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC



2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED COMPANY SHARE OPTION SCHEME



3. PERIOD OF RETURN:

FROM: 12 APRIL 2007 TO: 25 OCTOBER 2007



4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

150,750 ORDINARY SHARES OF 0.1P EACH



5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

NIL ORDINARY SHARES OF 0.1P EACH



6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

150,750 ORDINARY SHARES OF 0.1P EACH



7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

507,146 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003



PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.

120,297,135 ORDINARY SHARES OF 0.1P EACH







                        BLOCKLISTING SIX MONTHLY REVIEW


1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC



2. NAME OF SCHEME:

GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME



3. PERIOD OF RETURN:

FROM: 12 APRIL 2007 TO: 25 OCTOBER 2007


4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

596,262 ORDINARY SHARES OF 0.1P EACH



5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

200,800 ORDINARY SHARES OF 0.1P EACH



6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

395,462 ORDINARY SHARES OF 0.1P EACH



7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003



PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.


120,297,135 ORDINARY SHARES OF 0.1P EACH






                        BLOCKLISTING SIX MONTHLY REVIEW



1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC



2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001


3. PERIOD OF RETURN:

FROM: 12 APRIL 2007 TO: 25 OCTOBER 2007


4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

423,758 ORDINARY SHARES OF 0.1P EACH



5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

NIL ORDINARY SHARES OF 0.1P EACH


6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

423,758 ORDINARY SHARES OF 0.1P EACH



7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004



PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.


120,297,135 ORDINARY SHARES OF 0.1P EACH







                        BLOCKLISTING SIX MONTHLY REVIEW



1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC



2. NAME OF SCHEME:

GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001



3. PERIOD OF RETURN:

FROM: 12 APRIL 2007 TO: 25 OCTOBER 2007



4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED
UNDER SCHEME AT END OF THE LAST PERIOD:

1,276,492 ORDINARY SHARES OF 0.1P EACH



5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

NIL ORDINARY SHARES OF 0.1P EACH



6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

1,276,492 ORDINARY SHARES OF 0.1P EACH



7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY
LISTED AND THE DATE OF ADMISSION:

1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004



PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER
FOR US TO UPDATE OUR RECORDS.

120,297,135 ORDINARY SHARES OF 0.1P EACH


For further information, please contact:

Jonathan Laughton, GW Pharmaceuticals plc

Telephone: [phone]





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BLRFELFLDBBLFBL